Stocks Technology CDLX
NASDAQ · TechnologyCardlytics, Inc. (CDLX)
Cardlytics, Inc. brought in $190M of revenue over the twelve months to June 30, 2026, down 25.6% from a year earlier. It posted a net loss of $100.3M. Operating cash flow minus capital spending left $8.8M of free cash flow in fiscal 2025. At June 30, 2026 it held $28M in cash against $184.4M of debt. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 5, 2026.
Key facts about Cardlytics, Inc.
- Net worth
- Cardlytics, Inc. has a market value (market cap) of $10M at the latest share price, and shareholders' equity of -$16M on its balance sheet at June 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
- Revenue and profit
- In fiscal 2025 revenue was $233.3M (-16.2% year on year), with a net loss of $103.5M. Over the 12 months to June 30, 2026: revenue $190M, net loss $100.3M.
- Cash flow
- In fiscal 2025 operations brought in $9.3M of cash; after $480K of capital spending, free cash flow was $8.8M.
- Latest report
- The latest periodic report (quarterly report, 10-Q) was filed with the SEC on August 5, 2026 and covers the period to June 30, 2026. Open on SEC EDGAR
- Next earnings report
- Cardlytics, Inc.'s next report was expected around November 4, 2026 and is not on file with the SEC yet.
What Cardlytics, Inc. does
Cardlytics, Inc. is registered with the SEC under industry code SIC 7370 (Services-Computer Programming, Data Processing, Etc.). Its shares trade on NASDAQ under the ticker CDLX.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | $233.3M | -$103.5M | -$1.95 | $8.8M |
| 2024 | $278.3M | -$189.3M | -$3.91 | -$10.4M |
| 2023 | $309.2M | -$134.7M | -$3.69 | -$852K |
| 2022 | $298.5M | -$465.3M | -$13.92 | -$55.1M |
| 2021 | $267.1M | -$128.6M | -$3.99 | -$41.6M |
| 2020 | $186.9M | -$55.4M | -$2.04 | -$13M |
Earnings: every quarter and the next report date
Full financial statements: income, balance sheet and cash flow
Where CDLX ranks in Technology
Latest SEC filings
What Cardlytics, Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.
- September 11, 2026
- August 5, 2026Quarterly report 10-Q · period to June 30, 2026Revenue fell 36% to $36.9M versus the same quarter last year; net loss of $14.9M.
- August 5, 2026
- June 3, 2026
- May 20, 2026
- May 12, 2026
- May 7, 2026Quarterly report 10-Q · period to March 31, 2026Revenue fell 39% to $34.3M versus the same quarter last year; net loss of $4.5M.
- May 7, 2026
- April 9, 2026
- April 9, 2026Additional proxy material DEFA14A
What is CDLX worth? A DCF from its reported cash flow
Insider trades
What the people running Cardlytics, Inc. did with its shares, from the Form 4 filings they must send the SEC within two business days.
Insiders sold $100.6K worth of shares in the last 90 days and bought none on the open market.
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| October 2, 2026 | Gupta AmitChief Executive Officer, Director | Sold | 7,382 | $18.7K |
| October 1, 2026 | Gupta AmitChief Executive Officer, Director | Exercised options | 18,750 | - |
| October 1, 2026 | Gupta AmitChief Executive Officer, Director | Exercised options | 12,500 | - |
| October 1, 2026 | Gupta AmitChief Executive Officer, Director | Sold | 10,351 | $28.1K |
| August 18, 2026 | Gupta AmitChief Executive Officer, Director | Sold | 6,676 | $26.9K |
| August 17, 2026 | Gupta AmitChief Executive Officer, Director | Sold | 6,785 | $26.9K |
| August 16, 2026 | Gupta AmitChief Executive Officer, Director | Exercised options | 12,500 | - |
| August 16, 2026 | Gupta AmitChief Executive Officer, Director | Exercised options | 12,500 | - |
Who owns CDLX
Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.
5% holders
| Holder | Of class | Filed |
|---|---|---|
| CAS Investment Partners, LLC13D, may seek influence with 4 related filers | 9.8% | August 20, 2025 |
Largest institutional holders
Insiders
10 insiders reported holding 938,783 shares in total, about $1.6M at the last price.
| Holder | Shares |
|---|---|
| Evans David ThomasChief Financial Officer | 317,930 |
| DeSieno AlexisChief Financial Officer | 201,159 |
| Gupta AmitChief Executive Officer, Director | 138,906 |
| Klinck John L. Jr.Director | 89,593 |
| Hill Scott ADirector | 68,748 |
| Hornsey LianeDirector | 33,326 |
| Fernandez Andre JDirector | 26,310 |
| Francis Jonathan EdwardDirector | 26,310 |
| Lynton Nicholas HollmeyerChief Legal & Privacy Officer | 19,353 |
| Gupta Srishti A.Director | 17,148 |
Questions about CDLX
What does Cardlytics, Inc. do?
Cardlytics, Inc. is a company in the Technology sector, listed on NASDAQ as CDLX. Its shares trade on NASDAQ under the ticker CDLX.
What is Cardlytics, Inc.'s net worth?
Cardlytics, Inc. has a market value (market cap) of $10M at the latest share price, and shareholders' equity of -$16M on its balance sheet at June 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
Is Cardlytics, Inc. profitable?
No. Over the twelve months to June 30, 2026 it reported a net loss of $100.3M on revenue of $190M.
How much revenue does Cardlytics, Inc. make?
Over the twelve months to June 30, 2026 Cardlytics, Inc. reported revenue of $190M. That is 25.6% less than a year earlier.
When did Cardlytics, Inc. last report?
Its most recent periodic report is the quarterly report (10-Q) filed on August 5, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the insider trade from October 2, 2026.
When is Cardlytics, Inc.'s next earnings report?
Cardlytics, Inc.'s next report was expected around November 4, 2026 and is not on file with the SEC yet.
Similar companies
Compare CDLX with
Follow CDLX
Get an email when Cardlytics, Inc. files with the SEC: results, executive changes, material agreements and annual reports.
Where the numbers come from
Financial figures are the values Cardlytics, Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.